OOIR: Observatory of International Research

Papers

(The H4-Index of Brain and Behavior is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Mental health and quality of life among healthcare professionals during the COVID‐19 pandemic in India	153
The relationship among fear and anxiety of COVID‐19, pregnancy experience, and mental health disorder in pregnant women: A structural equation model	121
Longitudinal changes in anxiety and psychological distress, and associated risk and protective factors during the first three months of the COVID‐19 pandemic in Germany	108
Neuropsychological deficits in patients with cognitive complaints after COVID‐19	89
Gender differences in emotional response to the COVID‐19 outbreak in Spain	80
Cognitive frailty as a predictor of adverse outcomes among older adults: A systematic review and meta‐analysis	74
Molecular links between endocrine, nervous and immune system during chronic stress	72
Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis	71
Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta‐analysis	66
Variability of EEG electrode positions and their underlying brain regions: visualizing gel artifacts from a simultaneous EEG‐fMRI dataset	59
Gut microbiota variations in patients diagnosed with major depressive disorder—A systematic review	51
Burnout, depersonalization, and anxiety contribute to post‐traumatic stress in frontline health workers at COVID‐19 patient care, a follow‐up study	51
A mediating role for mental health in associations between COVID‐19‐related self‐stigma, PTSD, quality of life, and insomnia among patients recovered from COVID‐19	49
The Danish Multiple Sclerosis Registry	49
Psychometric properties of Structured Clinical Interview for DSM‐5 Disorders‐Clinician Version (SCID‐5‐CV)	49
Facial palsy during the COVID‐19 pandemic	49
Multimodal treatment of persistent postural–perceptual dizziness	46
Cerebral blood flow impairment and cognitive decline in heart failure	45
Fear of hypoglycemia—An underestimated problem	44
Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency	44
Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease	42
Profiling COVID‐related experiences in the United States with the Epidemic‐Pandemic Impacts Inventory: Linkages to psychosocial functioning	41
The burden of epilepsy and unmet need in people with focal seizures	39
Prognostic prediction of hypertensive intracerebral hemorrhage using CT radiomics and machine learning	39
Study on the neuroprotective effects of Genistein on Alzheimer’s disease	39

Predictors of response to erenumab after 12 months of treatment	36
Schizophrenia outcomes in the 21st century: A systematic review	34
Prevalence and risk factors of mental distress in China during the outbreak of COVID‐19: A national cross‐sectional survey	34
High fibrinogen‐to‐albumin ratio is associated with hemorrhagic transformation in acute ischemic stroke patients	33
Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?	33
Personality profile of individual sports champions	33
Associations between coronary heart disease and risk of cognitive impairment: A meta‐analysis	33